The vitamin D receptor (VDR) is expressed in non-epithelial prostate cancer cells and the benign stroma surrounding prostate tumors, suggesting that vitamin D may modulate the prostate tumor microenvironment, particularly in the context of antiandrogen therapy [53]. This evidence concerns the gene VDR and prostate carcinoma.